NCT06728826

Brief Summary

The goal of PREACT-AF is to learn if posterior pericardiotomy works to prevent the incidence of postoperative atrial fibrillation (POAF) in patients undergoing cardiac surgery. The main questions it aims to answer are: Does posterior pericardiotomy prevent the incidence of POAF for participants after cardiac surgery? What medical problems do participants have when undergoing posterior pericardiotomy?

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
648

participants targeted

Target at P75+ for not_applicable

Timeline
1mo left

Started Jan 2025

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress95%
Jan 2025Jun 2026

First Submitted

Initial submission to the registry

December 8, 2024

Completed
3 days until next milestone

First Posted

Study publicly available on registry

December 11, 2024

Completed
21 days until next milestone

Study Start

First participant enrolled

January 1, 2025

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2025

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2026

Expected
Last Updated

December 11, 2024

Status Verified

December 1, 2024

Enrollment Period

11 months

First QC Date

December 8, 2024

Last Update Submit

December 8, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • In-hospital post-operative atrial fibrillation

    Number of patients with post-operative atrial fibrillation within the first 5 days postoperatively or up to hospital discharge, whichever occurs first

    Within 5 days after index cardiac surgery

Secondary Outcomes (6)

  • Length of post-operative in-hospital stay

    Over the duration of the follow-up period to a common end date (mean follow-up of 5 years).

  • Pericardial effusion without tamponade

    From index surgery completion to within 30 days of index surgery

  • Death

    From index surgery completion to within 30 days of index surgery

  • Ischemic stroke or systemic arterial embolism

    From index surgery completion to within 30 days of index surgery

  • Hospital readmission or unplanned hospital visit

    From index surgery completion to within 30 days of index surgery

  • +1 more secondary outcomes

Other Outcomes (5)

  • Number of patients with phrenic nerve injuries

    Within 30 days of index surgery

  • Number of patients with left pleural interventions

    Within 30 days of index surgery

  • Number of patients with esophageal injuries

    Within 30 days of index surgery

  • +2 more other outcomes

Study Arms (2)

Posterior Pericardiotomy Group

EXPERIMENTAL

The surgeon will perform posterior pericardiotomy during the patient's cardiac surgery.

Procedure: Posterior Pericardiotomy

No Posterior Pericardiotomy Group

NO INTERVENTION

The surgeon will not perform posterior pericardiotomy during the patient's cardiac surgery.

Interventions

The surgeon will perform a posterior pericardiotomy while the patient is on cardiopulmonary bypass. In detail, the surgeon will use cautery to make a 4- to 5-cm opening in pericardium between the left inferior pulmonary vein and the diaphragm. Then a soft channel drain will be placed through the posterior pericardium, the pericardiotomy and into the left pleural space.

Posterior Pericardiotomy Group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients greater than or equal to 18 years of age
  • Requiring surgical intervention on the proximal aorta, cardiac valves, and/or coronary arteries
  • Able to provide informed consent

You may not qualify if:

  • History of atrial fibrillation or flutter
  • Prior cardiac surgery requiring opening of the pericardium
  • Previous surgical instrumentation of the left pleural cavity
  • Patient undergoing minimally invasive cardiac surgery

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Changhai Hospital

Shanghai, 200433, China

Location

MeSH Terms

Conditions

Atrial FibrillationCardiovascular Diseases

Condition Hierarchy (Ancestors)

Arrhythmias, CardiacHeart DiseasesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Lin Han, M.D. Ph.D.

    Naval Medical University Changhai Hospital

    PRINCIPAL INVESTIGATOR
  • Hao Zhang, M.D. Ph.D.

    Naval Medical University Changhai Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Hao Zhang, M.D. Ph.D.

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 8, 2024

First Posted

December 11, 2024

Study Start

January 1, 2025

Primary Completion

December 1, 2025

Study Completion (Estimated)

June 1, 2026

Last Updated

December 11, 2024

Record last verified: 2024-12

Locations